After systemic administration the drug distributes rapidly to highly perfused tissues, with an initial distribution half-life of 8-9 minutes and an elimination half-life averaging 90-120 minutes in healthy adults
Weight loss often becomes more noticeable during this phase, though the amount varies by individual and medication
Liraglutide treatment prevented functional decline within the default mode network structures in contrast to placebo, further suggesting that GLP-1 receptor agonists can exert neuroprotective effects in AD and provide a promising disease-modifying strategy
For individuals relying on semaglutide for diabetes management, even temporary loss of glycemic control can have metabolic consequences
Injections require a clinic visit and may not suit patients with needle phobia or scheduling constraints
Grewal S, McKinlay S, Kapczinski F, Pfaffenseller B, Wollenhaupt-Aguiar B